Table 2 Comparison of patients who died during LCP care vs LCP-discontinued patients

Number (n)

144

15

No IPT consensus on LCP

-

2 (13 %)

Age (years)^a

69.5 (28–97)

74 (51–87)

SPCU^b stay (hours)^a

130 (3–941)

355 (52–985)

Time on LCP (hours)^a,c

22.5 (0–240)

46 (12–143)

Gender

 Female

78 (54 %)

7 (47 %)

 Male

66 (46 %)

8 (53 %)

Cancer

124 (86 %)

11 (73 %)

Non-cancer

20 (14 %)

4 (27 %)

PPI

n = 68

n = 10

 1–5 (>3 weeks)

14 (20.6 %)

4 (26.7 %)

 6–15 (<3 weeks)

54 (79.4 %)

6 (60 %)

PaP-S

n = 72

n = 7

 >70 % (0.5–5.0)

12 (16.7 %)

1 (14.3 %)

 30–70 % (6.0–11.0)

27 (37.5 %)

3 (42.9 %)

 <30 % (11.5–17.5)

33 (45.8 %)

3 (42.9 %)

PPS

n =73

n = 10

 100–60 %

2 (2.7 %)

2 (20 %)

 50–30 %

35 (47.9 %)

2 (20 %)

 10–20 %

36 (49.3 %)

6 (60 %)

Palliative stage

n = 120

n = 12

 Rehabilitation phase

2 (1.7 %)

1 (8.3 %)

 Early end of life phase

30 (25.0 %)

4 (33.3 %)

 Late end of life phase

75 (62.5 %)

6 (50 %)

 Terminal phase

13 (10.8 %)

1 (8.3 %)

Quality of life ^d

Karnofsky

n = 69

n = 7

 >30 %

20 (29 %)

1 (14 %)

 <30 %

49 (71 %)

6 (86 %)

ECOG (0–5)^a

4 (1–4), n = 129

4 (3–4), n = 11

Barthel (0–100)^a

15 (0–95), n = 138

20 (0–70), n = 12

AEDL (0–36)^a

18 (3–36), n = 144

19 (8–35), n = 15

Total Symptom score (0–51)^a

15 (5–30), n = 144

14 (8–24), n = 15